---

Role of neo-adjuvant chemotherapy in locally advanced nasopharyngeal carcinoma

---

Review Article

Author Details : Pratiksha Pawar*, Pranay Bhandari, Ameya Bihani, Kunal Gupta, Taha Sethjiwala

Volume : 8, Issue : 2, Year : 2022

Article Page : 51-56

https://doi.org/10.18231/j.ijashnb.2022.013

Suggest article by email

Get Permission

---

Abstract

Nasopharyngeal carcinoma (NPC) is a rare type of tumor which arises from the surface and lining epithelium of nasopharynx. Management of nasopharyngeal carcinoma is one of the greatest clinical challenges but it is radiosensitive and chemosensitive; excellent tumor control can be attained with radiotherapy with or without adjuvant therapies concurrent chemoradiation therapy. This review will focus on role of neoadjuvant chemotherapy in nasopharyngeal carcinoma on disease free survival (DFS), distant metastases free survival and overall survival (OS) and systemic toxicities, indications and choice and number of cycles of regimen for neoadjuvant chemotherapy.
 

Keywords: Nasopharyngeal Carcinoma, Nasopharynx, Chemotherapy, Radiation Therapy, Concurrent Chemoradiotherapy, CCRT, NPC

How to cite : Pawar P, Bhandari P, Bihani A, Gupta K, Sethjiwala T, Role of neo-adjuvant chemotherapy in locally advanced nasopharyngeal carcinoma. IP Indian J Anat Surg Head Neck Brain 2022;8(2):51-56

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.